ACERUS PHARMACEUTICALS Profitability Analysis

ASPCF -  USA Stock  

USD 0.029  0.00  0.00%

For ACERUS PHARMACEUTICALS profitability analysis, we use financial ratios and fundamental drivers that measure the ability of ACERUS PHARMACEUTICALS to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well ACERUS PHARMACEUTICALS CORP utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between ACERUS PHARMACEUTICALS's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of ACERUS PHARMACEUTICALS CORP over time as well as its relative position and ranking within its peers. Please continue to Trending Equities.

Search Current Profitability Trends 

 
Refresh
The market value of ACERUS PHARMACEUTICALS is measured differently than its book value, which is the value of ACERUS that is recorded on the company's balance sheet. Investors also form their own opinion of ACERUS PHARMACEUTICALS's value that differs from its market value or its book value, called intrinsic value, which is ACERUS PHARMACEUTICALS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACERUS PHARMACEUTICALS's market value can be influenced by many factors that don't directly affect ACERUS PHARMACEUTICALS underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACERUS PHARMACEUTICALS's value and its price as these two are different measures arrived at by different means. Investors typically determine ACERUS PHARMACEUTICALS value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACERUS PHARMACEUTICALS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

ACERUS PHARMACEUTICALS Shares Outstanding vs. Net Income Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining ACERUS PHARMACEUTICALS's current stock value. Our valuation model uses many indicators to compare ACERUS PHARMACEUTICALS value to that of its competitors to determine the firm's financial worth.
ACERUS PHARMACEUTICALS CORP is rated fourth in net income category among related companies. It is rated second in shares outstanding category among related companies .

ACERUS Shares Outstanding vs. Net Income

Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
ACERUS PHARMACEUTICALS 
Net Income 
 = 
(Rev + Gain) 
-  
(Exp + Loss) 
(34.05 M)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
ACERUS PHARMACEUTICALS 
Shares Outstanding 
 = 
Public Shares 
Repurchased 
1.54 B
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

ACERUS Shares Outstanding Comparison

ACERUS PHARMACEUTICALS is currently under evaluation in shares outstanding category among related companies.

ACERUS PHARMACEUTICALS Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in ACERUS PHARMACEUTICALS, profitability is also one of the essential criteria for including it into their portfolios because, without profit, ACERUS PHARMACEUTICALS will eventually generate negative long term returns. The profitability progress is the general direction of ACERUS PHARMACEUTICALS's change in net profit over the period of time. It can combine multiple indicators of ACERUS PHARMACEUTICALS, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for mens and womens health. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada. ACERUS PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 10 people.

ACERUS Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on ACERUS PHARMACEUTICALS. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of ACERUS PHARMACEUTICALS position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the ACERUS PHARMACEUTICALS's important profitability drivers and their relationship over time.

Use ACERUS PHARMACEUTICALS in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ACERUS PHARMACEUTICALS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACERUS PHARMACEUTICALS will appreciate offsetting losses from the drop in the long position's value.

ACERUS PHARMACEUTICALS Pair Trading

ACERUS PHARMACEUTICALS CORP Pair Trading Analysis

Correlation analysis and pair trading evaluation for ACERUS PHARMACEUTICALS and Merck Kgaa ADR. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Use Investing Themes to Complement your ACERUS PHARMACEUTICALS position

In addition to having ACERUS PHARMACEUTICALS in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Electrical Equipment Thematic Idea Now

Electrical Equipment
Electrical Equipment Theme
Fama and French focuses on testing asset pricing under different economic assumptions. Electrical Equipment theme has 31 constituents.
View All  Next Launch Electrical Equipment
Please continue to Trending Equities. Note that the ACERUS PHARMACEUTICALS information on this page should be used as a complementary analysis to other ACERUS PHARMACEUTICALS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for ACERUS OTC Stock analysis

When running ACERUS PHARMACEUTICALS price analysis, check to measure ACERUS PHARMACEUTICALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACERUS PHARMACEUTICALS is operating at the current time. Most of ACERUS PHARMACEUTICALS's value examination focuses on studying past and present price action to predict the probability of ACERUS PHARMACEUTICALS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ACERUS PHARMACEUTICALS's price. Additionally, you may evaluate how the addition of ACERUS PHARMACEUTICALS to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
To fully project ACERUS PHARMACEUTICALS's future profitability" href="/future-stock-price/ASPCF">future profitability, investors should examine all historical financial statements" href="/financial-statements/ASPCF">financial statements. These statements provide investors with a comprehensive snapshot of the financial position" href="/financial-statements/ASPCF">financial position of ACERUS PHARMACEUTICALS at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements" href="/financial-statements/ASPCF">financial statements. These documents include ACERUS PHARMACEUTICALS's income statement, its balance sheet, and the statement of cash flows.
Potential ACERUS PHARMACEUTICALS investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although ACERUS PHARMACEUTICALS investors may work on each financial statement separately, they are all related. The changes in ACERUS PHARMACEUTICALS's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ACERUS PHARMACEUTICALS's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.